New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Forte Biosciences, Inc.
FBRX
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

7M

Biotechnology

Next Earning date - 11 Nov 2024

7M

Biotechnology

Next Earning date - 11 Nov 2024

4.68USD
Shape-0.01 ( -0.25%)
favorite-chart

Relative Strenght

16
favorite-chart

Volume Buzz

76%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

78%

Quote Panel

Shape
Updated October 27, 2024
1W 0.86 % 1M -16.28 % 3M -66.48 % 1Y -62.56 %

Key Metrics

Shape
  • Market Cap

    6.83M


  • Shares Outstanding

    1.46M


  • Share in Float

    1.30M


  • Dividende

    0


  • Earning Date

    11 Nov 2024


  • Price Target

    4.6785


  • Average Volume

    9731


  • Beta

    1.429


  • Range

    4.44-21.25


  • Industry

    Biotechnology


  • Website

    https://www.fortebiorx.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

1138.56x

P/S Ratio

12.72x

P/B Ratio

0.0

Debt/Equity

-595966.7%

Net Margin

$-17.3

EPS

How FBRX compares to sector?

P/E Ratio

Relative Strength

Shape

FBRX

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape
0

$18.25

Shape-6659%

2025-EPS

0

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Rodman & Renshaw

initialise

Previous: Not converted

2024-06-18

Now: Buy

Brookline Capital

initialise

Previous: Not converted

2024-05-29

Now: Buy

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-4.50
vs -13.50

Q4.22

arrow
arrow

N/A

-6.00
vs -5.25

Q1.23

arrow
arrow

N/A

-8.00
vs -4.25

Q2.23

arrow
arrow

N/A

-10.50
vs -5.25

Q3.23

arrow
arrow

N/A

-6.50
vs -4.50

Q4.23

arrow
arrow

N/A

-1.00
vs -6.00

Q1.24

arrow
arrow

N/A

-4.00
vs -8.00

Q2.24

arrow
arrow

N/A

-6.75
vs -10.50

Q3.24

arrow
arrow

N/A

-6.33
vs -6.50

Q4.24

arrow
arrow

N/A

-4.25
vs -1.00

Sales GrowthShape

status-upYoY

Current

Estimates

Q1.22

arrow
arrow

NA

NA  vs NA

Q2.22

arrow
arrow

NA

NA  vs NA

Q3.22

arrow
arrow

NA

NA  vs NA

Q4.22

arrow
arrow

NA

NA  vs NA

Q1.23

arrow
arrow

NA

NA  vs NA

Q2.23

arrow
arrow

NA

NA  vs NA

Q3.23

arrow
arrow

NA

NA  vs NA

Q4.23

arrow
arrow

NA

6K  vs NA

Q1.24

arrow
arrow

NA

NA  vs NA

Q2.24

arrow
arrow

NA

NA  vs NA

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-8%

-0.08
vs -0.08

Q4.22

arrow
arrow

-13%

-0.13
vs -0.08

Q1.23

arrow
arrow

-20%

-0.20
vs -0.13

Q2.23

arrow
arrow

-36%

-0.36
vs -0.20

Q3.23

arrow
arrow

-25%

-0.25
vs -0.36

Q4.23

arrow
arrow

-17%

-0.17
vs -0.25

Q1.24

arrow
arrow

-26%

-0.26
vs -0.17

Q2.24

arrow
arrow

-74%

-0.74
vs -0.26

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

26

26
vs 32

-19%

Q4.22

arrow
arrow

33

33
vs 26

27%

Q1.23

arrow
arrow

30

30
vs 33

-9%

Q2.23

arrow
arrow

31

31
vs 30

3%

Q3.23

arrow
arrow

32

32
vs 31

3%

Q4.23

arrow
arrow

35

35
vs 32

9%

Q1.24

arrow
arrow

32

32
vs 35

-9%

Q2.24

arrow
arrow

33

33
vs 32

3%

Earnings Growth

Latest News